Signe Sørensen Torekov

Research output

Research output per year 2004 2015 2016 2017 2018 2019 2019

• 44 Journal article
• 2 Comment/debate
• 2 Review
• 2 Net publication - Internet publication
• 2 More
  • 1 Conference article
  • 1 Contribution to newspaper - Comment/debate

Research output per year

Research output per year

Search results

• 2019

  Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists

  Christensen, R. M., Juhl, C. R. & Torekov, S. S., 1 Aug 2019, In: Drug Safety. 42, 8, p. 957-971 15 p.

  Research output: Contribution to journal › Review › peer-review

  • Glucagon-Like Peptide-1 Receptor Agonist 100%
  • Glucagon-Like Peptide-1 Receptor 66%
  • Liraglutide 65%
  • semaglutide 44%
  • Risk Assessment 42%
  5 Citations (Scopus)

• Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test: [Meeting Abstract}

  Jonsson, A., Stinson, S. E., Torekov, S. S., Clausen, T. D., Kelstrup, L., Faerch, K., Grarup, N., Pedersen, O., Mathiesen, E. R., Damm, P., Joergensen, M. E., Witte, D. R., Holst, J. J. & Hansen, T., 2019, In: Diabetologia. 62, Supl. 1/SI, p. S170-S170 339.

  Research output: Contribution to journal › Conference article › Research

• Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures

  Lundgren, J. R., Faerch, K., Witte, D. R., Jonsson, A. E., Pedersen, O., Hansen, T., Lauritzen, T., Holst, J. J., Vistisen, D., Jorgensen, M. E., Torekov, S. S. & Johansen, N. B., 5 Oct 2019, In: Cardiovascular Diabetology. 18, 1, 9 p., 130.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Blood Pressure 54%
  • Glucose 53%
  • Confidence Intervals 25%
  • Pulse Wave Analysis 19%
  14 Downloads (Pure)

• Habitual activity associates with lower fasting and greater glucose-induced GLP-1 response in men

  Janus, C., Vistisen, D., Amadid, H., Witte, D. R., Lauritzen, T., Brage, S., Bjerregaard, A-L., Hansen, T., Holst, J. J., Jørgensen, M. E., Pedersen, O., Færch, K. & Torekov, S., 2019, In: Endocrine Connections.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Fasting 68%
  • Exercise 55%
  • Glucose 53%
  • Overweight 12%
  1 Citation (Scopus)

• Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet

  Jensen, S. B. K., Lundgren, J. R., Janus, C., Juhl, C. R., Olsen, L. M., Rosenkilde, M., Holst, J. J., Stallknecht, B. M., Madsbad, S. & Torekov, S. S., 1 Nov 2019, In: BMJ Open. 9, 11, 10 p., e031431.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Liraglutide 100%
  • Glucagon-Like Peptide-1 Receptor 92%
  • Caloric Restriction 89%
  • Weight Loss 58%
  • Maintenance 50%
  2 Citations (Scopus)
• 2018

  Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses

  Engelbrechtsen, L., Mahendran, Y., Jonsson, A., Gjesing, A. P., Weeke, P. E., Jørgensen, M. E., Færch, K., Witte, D. R., Holst, J. J., Jørgensen, T., Grarup, N., Pedersen, O., Vestergaard, H., Torekov, S., Kanters, J. K. & Hansen, T., 16 Mar 2018, In: B M C Genetics. 19, 1, p. 1-9 9 p., 15.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Voltage-Gated Potassium Channels 100%
  • Incretins 98%
  • Ether 84%
  • Glucagon 79%
  • Fasting 60%
  3 Citations (Scopus)

  63 Downloads (Pure)

• Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids

  Wewer Albrechtsen, N. J., Færch, K., Jensen, T. M., Witte, D. R., Pedersen, J., Mahendran, Y., Jonsson, A. E., Galsgaard, K. D., Winther-Sørensen, M., Torekov, S. S., Lauritzen, T., Pedersen, O., Knop, F. K., Hansen, T., Jørgensen, M. E., Vistisen, D. & Holst, J. J., 1 Mar 2018, In: Diabetologia. 61, 3, p. 671-680

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon 100%
  • Insulin Resistance 78%
  • Fasting 76%
  • Amino Acids 67%
  • Liver 49%
  27 Citations (Scopus)

• Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL

  Torekov, S. S., 1 Aug 2018, In: Cardiovascular Research. 114, 10, p. e70-e71 2 p.

  Research output: Contribution to journal › Comment/debate › Research › peer-review

  4 Citations (Scopus)

• Hvordan undgår man, at de tabte kilo kommer på igen?

  Christensen, B. J., Iepsen, E. P. W. & Torekov, S. S., 29 May 2018, Forskerzonen.

  Research output: Other contribution › Net publication - Internet publication › Communication

• Instrumentalization of eating improves weight loss maintenance in obesity

  Christensen, B. J., Iepsen, E. P. W., Lundgren, J. R., Holm, L., Madsbad, S., Holst, J. J. & Torekov, S. S., 1 Feb 2018, In: Obesity Facts. 10, 6, p. 633-647 15 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • instrumentalization 100%
  • eating behavior 71%
  • Weight Loss 61%
  • Eating 55%
  • Maintenance 52%
  11 Citations (Scopus)

  201 Downloads (Pure)

• Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist

  Iepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J-C. & Torekov, S. S., 3 Jul 2018, In: Cell Metabolism. 28, 1, p. 23-32.e3

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Receptor, Melanocortin, Type 4 100%
  • Liraglutide 95%
  • Glucagon-Like Peptide-1 Receptor 87%
  • Obesity 47%
  • Mutation 37%
  32 Citations (Scopus)

• Plasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass Surgery

  Wewer Albrechtsen, N. J., Geyer, P. E., Doll, S., Treit, P. V., Bojsen-Møller, K. N., Martinussen, C., Jørgensen, N. B., Torekov, S. S., Meier, F., Niu, L., Santos, A., Keilhauer, E. C., Holst, J. J., Madsbad, S. & Mann, M., 26 Dec 2018, In: Cell Systems. 7, 6, p. 601-612

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Gastric Bypass 100%
  • Proteome 90%
  • Homeostasis 63%
  • Lipids 56%
  • Bariatric Surgery 48%
  31 Citations (Scopus)

  40 Downloads (Pure)
• 2017

  Chronic intrahypothalamic rather than subcutaneous liraglutide treatment reduces body weight gain and stimulates the melanocortin receptor system

  Kaineder, K., Birngruber, T., Rauter, G., Obermüller, B., Eichler, J., Münzker, J., Al-Zoughbi, W., Mautner, S. I., Torekov, S. S., Hartmann, B., Kotzbeck, P. & Pieber, T. R., 1 Aug 2017, In: International Journal of Obesity. 41, p. 1263-1270 8 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Melanocortin Receptors 100%
  • Liraglutide 91%
  • Weight Gain 59%
  • Body Weight 46%
  • Adipose Tissue 39%
  4 Citations (Scopus)

  86 Downloads (Pure)

• Glucagon-Like Peptide 1: A Predictor of Type 2 Diabetes?

  Larsen, M. P. & Torekov, S. S., 2017, In: Journal of Diabetes Research. 2017, 13 p., 7583506.

  Research output: Contribution to journal › Review › peer-review

  • Glucagon-Like Peptide 1 100%
  • Type 2 Diabetes Mellitus 64%
  • Glucose Intolerance 60%
  • Fasting 45%
  • Glucose 35%
  10 Citations (Scopus)

  45 Downloads (Pure)

• Glucose ingestion causes cardiac repolarization disturbances in type 1 long QT syndrome patients and healthy subjects

  Hyltén-Cavallius, L., Iepsen, E. W., Christiansen, M., Graff, C., Linneberg, A., Pedersen, O., Holst, J. J., Hansen, T., Torekov, S. S. & Kanters, J. K., Aug 2017, In: Heart Rhythm. 14, 8, p. 1165-1170 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Romano-Ward Syndrome 100%
  • Long QT Syndrome 77%
  • Eating 44%
  • Healthy Volunteers 39%
  • Glucose 37%
  6 Citations (Scopus)

• Health care professionals from developing countries report educational benefits after an online diabetes course

  Wewer Albrechtsen, N. J., Poulsen, K. W., Svensson, L. Ø., Jensen, L., Holst, J. J. & Torekov, S. S., 31 May 2017, In: B M C Medical Education. 17, 8 p., 97.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Health care professionals 100%
  • chronic illness 90%
  • developing country 68%
  • participation 11%
  • questionnaire 7%
  9 Citations (Scopus)

  70 Downloads (Pure)

• Patients with Long QT Syndrome Due to Impaired hERG-encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated with Reactive Hypoglycemia

  Hyltén-Cavallius, L., Iepsen, E. W., Wewer Albrechtsen, N. J., Svendstrup, M., Lubberding, A. F., Hartmann, B., Jespersen, T., Linneberg, A., Christiansen, M., Vestergaard, H., Pedersen, O., Holst, J. J., Kanters, J. K., Hansen, T. & Torekov, S. S., 2 May 2017, In: Circulation. 135, 18, p. 1705-1719 15 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Long QT Syndrome 100%
  • Incretins 99%
  • Potassium Channels 87%
  • Hypoglycemia 74%
  • Glucose 48%
  17 Citations (Scopus)

  84 Downloads (Pure)

• Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB

  Engelbrechtsen, L., Lundgren, J., Wewer Albrechtsen, N. J., Mahendran, Y., Iepsen, E. P. W., Finocchietto, P., Jonsson, A. E., Madsbad, S., Holst, J. J., Vestergaard, H., Hansen, T. & Torekov, S. S., Dec 2017, In: Obesity Science & Practice. 3, 4, p. 425-433 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Liraglutide 100%
  • Apolipoproteins B 79%
  • Cardiovascular Diseases 51%
  • Weight Loss 29%
  • Caloric Restriction 26%
  7 Citations (Scopus)

  146 Downloads (Pure)
• 2016

  Atrial Natriuretic Peptide in the high normal range is associated with lower prevalence of insulin resistance

  Jujić, A., Nilsson, P. M., Persson, M., Holst, J. J., Torekov, S. S., Lyssenko, V., Groop, L., Melander, O. & Magnusson, M., Apr 2016, In: The Journal of clinical endocrinology and metabolism. 101, 4, p. 1372-1380 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Atrial Natriuretic Peptide 100%
  • Atrial Natriuretic Factor 69%
  • Insulin Derivative 64%
  • Glucose-Dependent Insulinotropic Peptide 57%
  • Insulin Resistance 51%
  10 Citations (Scopus)

• Glucose-dependent insulinotropic polypeptide (GIP) is associated with lower LDL but unhealthy fat distribution, independent of insulin: The ADDITION-PRO study

  Møller, C. L., Vistisen, D., Færch, K., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Jørgensen, M. E., Torekov, S. S. & Juul Holst, J., Feb 2016, In: Journal of Clinical Endocrinology and Metabolism. 101, 2, p. 485– 493 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Insulinotropic 100%
  • Insulin Derivative 61%
  • oxidized low density lipoprotein 60%
  • Fat 59%
  • Polypeptide 49%
  23 Citations (Scopus)

• Insulin Resistance is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

  Faerch, K., Vistisen, D., Pacini, G., Torekov, S. S., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Jørgensen, M. E., Ahrén, B. & Holst, J. J., Nov 2016, In: Diabetes. 65, 11, p. 3473-3481 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon 100%
  • Insulin Resistance 78%
  • Fasting 76%
  • Glucose 60%
  • Hyperinsulinism 15%
  67 Citations (Scopus)

• Major rapid weight loss induces changes in cardiac repolarization

  Vedel-Larsen, E., Iepsen, E. P. W., Lundgren, J., Graff, C., Struijk, J. J., Hansen, T., Holst, J. J., Madsbad, S., Torekov, S. & Kanters, J. K., 1 May 2016, In: Journal of Electrocardiology. 49, 3, p. 467-472 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Weight Loss 100%
  • Fasting 58%
  • Glucose 45%
  • Potassium 43%
  • Electrocardiography 39%
  2 Citations (Scopus)

• Proteomics reveals the effects of sustained weight loss on the human plasma proteome

  Geyer, P. E., Wewer Albrechtsen, N. J., Tyanova, S., Grassl, N., Iepsen, E. P. W., Lundgren, J., Madsbad, S., Holst, J. J., Torekov, S. S. & Mann, M., 1 Dec 2016, In: Molecular Systems Biology. 12, 16 p., 901.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Plasma (human) 100%
  • Proteomics 77%
  • Plasma 58%
  • Proteome 56%
  • proteome 52%
  95 Citations (Scopus)

• Searching for the physiological role of glucose-dependent insulinotropic polypeptide

  Holst, J. J., Windeløv, J. A., Boer, G. A., Pedersen, J., Svendsen, B., Christensen, M., Torekov, S., Asmar, M., Hartmann, B. & Nissen, A., 1 Apr 2016, In: Journal of Diabetes Investigation. 7, S1, p. 8-12 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • gastric inhibitory polypeptide receptor 100%
  • Peptides 50%
  • Glucose 50%
  • Hormones 21%
  • Bone and Bones 17%
  22 Citations (Scopus)

• Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36

  Iepsen, E. W., Lundgren, J., Holst, J. J., Madsbad, S. & Torekov, S. S., Jun 2016, In: European Journal of Endocrinology. 174, 6, p. 775-784 10 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • peptide YY (3-36) 100%
  • Glucagon-Like Peptide 1 67%
  • Meals 51%
  • Weight Loss 47%
  • Maintenance 40%
  49 Citations (Scopus)

• Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels

  Engelbrechtsen, L., Iepsen, E. P. W., Galijatovic, E. A. A., Mahendran, Y., Lundgren, J. R., Jonsson, A. E., Madsbad, S., Holst, J. J., Vestergaard, H., Hansen, T. & Torekov, S. S., 1 Dec 2016, In: Metabolomics. 12, 12, p. 1-9 9 p., 181.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Branched-Chain Amino Acid 100%
  • Branched Chain Amino Acids 90%
  • Glucagon-Like Peptide 1 81%
  • Weight Loss 57%
  • Maintenance 48%
• 2015

  GLP-1 baseret behandling af diabetes og svær overvægt

  Iepsen, E. P. W., Torekov, S. S. & Holst, J. J., 2015, In: BestPractice. 9, 4, p. 10-12 3 p.

  Research output: Contribution to journal › Journal article › Communication

• GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women

  Iepsen, E. P. W., Lundgren, J. R., Hartmann, B., Pedersen, O., Hansen, T., Jørgensen, N. R., Jensen, J-E. B., Holst, J. J., Madsbad, S. & Torekov, S. S., 1 Aug 2015, In: The Journal of clinical endocrinology and metabolism. 100, 8, p. 2909 –2917 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide-1 Receptor Agonist 100%
  • Glucagon-Like Peptide-1 Receptor 66%
  • Osteogenesis 44%
  • Glucagon-Like Peptide 1 42%
  • Weight Loss 42%
  77 Citations (Scopus)

• Glucagon-Like Peptide-1 (GLP-1) Response to Oral Glucose is Reduced in Pre-diabetes, Screen-detected Type 2 Diabetes and Obesity, and Influenced by Sex: The ADDITION-PRO Study

  Færch, K., Torekov, S. S., Vistisen, D., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Sandbæk, A., Holst, J. J. & Jørgensen, M. E., Jul 2015, In: Diabetes. 64, p. 2513-25 13 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Type 2 Diabetes Mellitus 64%
  • Obesity 59%
  • Glucose 53%
  • Glucose Tolerance Test 21%
  144 Citations (Scopus)

• Liraglutide for Type 2 diabetes and obesity: a 2015 update

  Iepsen, E. P. W., Torekov, S. S. & Holst, J. J., 1 Jul 2015, In: Expert Review of Cardiovascular Therapy. 13, 7, p. 753-67 15 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  40 Citations (Scopus)

• New obesity treatment prevents bone loss during weight loss

  Torekov, S. S., 11 Jun 2015

  Research output: Other contribution › Net publication - Internet publication › Communication

• Ny fedmebehandling modvirker knogletab

  Torekov, S. S., 17 Jun 2015, In: Dagens Medicin. 1 p.

  Research output: Contribution to journal › Contribution to newspaper - Comment/debate

• Online diabeteskursus er en kæmpe succes

  Torekov, S. S., 2015, In: People.

  Research output: Contribution to journal › Journal article › Communication

• Response to Comment on Færch et al. GLP-1 Response to Oral Glucose Is Reduced in Prediabetes, Screen-Detected Type 2 Diabetes, and Obesity and Influenced by Sex: The ADDITION-PRO Study. Diabetes 2015;64:2513–2525

  Ferch, K., Torekov, S. S., Vistisen, D., Johansen, N. B., Witte, D. R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Sandbek, A., Holst, J. J. & Jørgensen, M. E., 1 Sept 2015, In: Diabetes. 64, 9, p. e30-e31

  Research output: Contribution to journal › Comment/debate › Research › peer-review

• Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss

  Iepsen, E. W., Lundgren, J., Dirksen, C., Jensen, J-E., Pedersen, O., Hansen, T., Madsbad, S., Holst, J. J. & Torekov, S. S., 8 May 2015, In: International journal of obesity (2005). 39, 5, p. 834-41 8 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide-1 Receptor 100%
  • Glucagon-Like Peptides 79%
  • Leptin 77%
  • Weight Loss 63%
  • Maintenance 54%
  49 Citations (Scopus)
• 2014

  A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk

  Torekov, S. S., Harsløf, T., Rejnmark, L., Eiken, P., Jensen, J. B., Herman, A. P., Hansen, T., Pedersen, O., Holst, J. J. & Langdahl, B. L., Apr 2014, In: The Journal of clinical endocrinology and metabolism. 99, 4, p. E729-33 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • gastric inhibitory polypeptide receptor 100%
  • Insulinotropic 99%
  • Amino Acid Substitution 64%
  • Bone Density 54%
  • Polypeptide 49%
  50 Citations (Scopus)

• Dose response of continuous subcutaneous infusion of recombinant glucagon-like peptide-1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus

  Torekov, S. S., Holst, J. J. & Ehlers, M. R., May 2014, In: Diabetes, Obesity and Metabolism. 16, 5, p. 451-6 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • glucagon-like peptide 1 (7-36)amide 100%
  • Subcutaneous Infusions 79%
  • Glucagon-Like Peptide 1 71%
  • Metformin 65%
  • Type 2 Diabetes Mellitus 45%
  11 Citations (Scopus)

• KCNQ1 Long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia

  Torekov, S. S., Iepsen, E., Christiansen, M., Linneberg, A., Pedersen, O., Holst, J. J., Kanters, J. K. & Hansen, T., Apr 2014, In: Diabetes. 63, 4, p. 1315-1325 11 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Long QT Syndrome 100%
  • Hyperinsulinism 84%
  • Hypoglycemia 74%
  • Glucose 48%
  • Glucose Tolerance Test 15%
  37 Citations (Scopus)

• Therapies for inter-relating diabetes and obesity - GLP-1 and obesity

  Iepsen, E. P. W., Torekov, S. S. & Holst, J. J., 1 Dec 2014, In: Expert Opinion on Pharmacotherapy. 15, 17, p. 2487-500 14 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Incretins 63%
  • Obesity 59%
  • Anti-Obesity Agents 34%
  • Glucagon-Like Peptide-1 Receptor 31%
  26 Citations (Scopus)
• 2012

  Impact of postprandial glycaemia on health and prevention of disease

  Blaak, E. E., Antoine, J-M., Benton, D., Björck, I., Bozzetto, L., Brouns, F., Diamant, M., Dye, L., Hulshof, T., Holst, J. J., Lamport, D. J., Laville, M., Lawton, C. L., Meheust, A., Nilson, A., Normand, S., Rivellese, A. A., Theis, S., Torekov, S. S. & Vinoy, S., Oct 2012, In: Obesity Reviews. 13, 10, p. 923-984

  Research output: Contribution to journal › Journal article › Research › peer-review

  • cardiovascular disease 100%
  • meals 84%
  • chronic illness 78%
  • Glucose 75%
  • Health 58%
  196 Citations (Scopus)

• Leptin og dens betydning for vægtvedligeholdelse

  Iepsen, E. P. W., Torekov, S. S. & Holst, J. J., 2012, In: Klinisk biokemi i Norden. 24, 4, p. 8-15 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review
• 2011

  An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future

  Madsbad, S., Kielgast, U., Asmar, M., Deacon, C. F., Torekov, S. S. & Holst, J. J., May 2011, In: Diabetes, Obesity and Metabolism. 13, 5, p. 394-407 14 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  157 Citations (Scopus)

• Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes

  Torekov, S. S., Kipnes, M. S., Harley, R. E., Holst, J. J. & Ehlers, M. R., Jul 2011, In: Diabetes, Obesity and Metabolism. 13, 7, p. 639-43 5 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • glucagon-like peptide 1 (7-36)amide 100%
  • Glucagon-Like Peptide 1 71%
  • Type 2 Diabetes Mellitus 45%
  • Placebos 34%
  • Fasting 32%
  17 Citations (Scopus)

• Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1

  Torekov, S. S., Ma, L., Grarup, N., Hartmann, B., Hainerová, I. A., Kielgast, U., Kissow, H., Rosenkilde, M., Lebl, J., Witte, D. R., Jørgensen, T., Sandbaek, A., Lauritzen, T., Madsen, O. D., Wang, J., Linneberg, A., Madsbad, S., Holst, J. J., Hansen, T., Pedersen, O., & 1 othersGIANT Consortium, Nov 2011, In: Diabetologia. 54, 11, p. 2820-31 12 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • Glucagon 88%
  • Fasting 68%
  • Alleles 62%
  • Insulin 58%
  13 Citations (Scopus)

• Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential

  Torekov, S. S., Madsbad, S. & Holst, J. J., Aug 2011, In: Obesity Reviews. 12, 8, p. 593-601 9 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Glucagon-Like Peptide 1 100%
  • surgery 88%
  • indication 74%
  • Obesity 59%
  • food 58%
  40 Citations (Scopus)
• 2010

  Family and population-based studies of variation within the ghrelin receptor locus in relation to measures of obesity

  Gjesing, A. P., Larsen, L. H., Torekov, S. S., Hainerová, I. A., Kapur, R., Johansen, A., Albrechtsen, A., Boj, S., Holst, B., Harper, A., Urhammer, S. A., Borch-Johnsen, K., Pisinger, C. H., Echwald, S. M., Eiberg, H. R. L., Astrup, A., Lebl, J., Ferrer, J., Schwartz, T. W., Hansen, T., & 1 othersPedersen, O., 2010, In: P L o S One. 5, 4, 8 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Ghrelin 100%
  • Growth Hormone 73%
  • ghrelin receptors 65%
  • Obesity 62%
  • Hormones 59%
  16 Citations (Scopus)

  4060 Downloads (Pure)
• 2008

  Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation

  Andreasen, C. H., Stender-Petersen, K. L., Mogensen, M. S., Torekov, S. S., Wegner, L., Andersen, G., Nielsen, A. L., Albrechtsen, A., Borch-Johnsen, K., Rasmussen, S. S., Clausen, J. O., Sandbaek, A., Lauritzen, T., Hansen, L., Jørgensen, T., Pedersen, O. & Hansen, T., 2008, In: Diabetes. 57, 1, p. 95-101 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Adipose Tissue 100%
  • Fats 90%
  • Obesity 83%
  • Alleles 43%
  • Type 2 Diabetes Mellitus 27%
  382 Citations (Scopus)
• 2007

  Genetic analysis of the estrogen-related receptor alpha and studies of association with obesity and type 2 diabetes

  Larsen, L. H., Rose, C. S., Sparsø, T., Overgaard, J., Torekov, S. S., Grarup, N., Jensen, D. P., Albrechtsen, A., Andersen, G., Ek, J., Glümer, C., Borch-Johnsen, K., Jørgensen, T., Hansen, T. & Pedersen, O., 2007, In: International Journal of Obesity. 31, 2, p. 365-70 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • ERRalpha estrogen-related receptor 100%
  • Type 2 Diabetes Mellitus 45%
  • Obesity 42%
  • Genetic Linkage 19%
  • PPAR gamma 16%
  9 Citations (Scopus)
• 2006

  Association between neuromedin U gene variants and overweight and obesity

  Hainerová, I., Torekov, S. S., Ek, J., Finková, M., Borch-Johnsen, K., Jørgensen, T., Madsen, O. D., Lebl, J., Hansen, T. & Pedersen, O., 2006, In: Journal of Clinical Endocrinology and Metabolism. 91, 12, p. 5057-63 7 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Hyperphagic 100%
  • Neuromedin U 88%
  • neuromedin U 77%
  • Obese Mice 54%
  • Neuropeptides 45%
  50 Citations (Scopus)

• Variants in the 5' region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects

  Torekov, S. S., Larsen, L. H., Andersen, G., Albrechtsen, A., Glümer, C., Borch-Johnsen, K., Jørgensen, T., Hansen, T. & Pedersen, O., 2006, In: Diabetologia. 49, 11, p. 2653-8 6 p.

  Research output: Contribution to journal › Journal article › Research › peer-review

  • Neuropeptide Y Receptors 100%
  • Appetite Regulation 89%
  • Hypothalamus 61%
  • European Continental Ancestry Group 61%
  • Central Nervous System 49%
  26 Citations (Scopus)